Theravance Inc. (INVA)

Last Year

05-Feb-22 -- 04-Feb-23

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

35

0

7

+1

0

+2

0

+3

Two Year Chart

05-Feb-21 -- 04-Feb-23

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
27-Apr-22 6:52 PM View:	25-Apr-22 Grant 0	Bickerstaff George Director		Theravance Inc. - INVA	10% 124.56K to 137.21K	0	0	--	--	Show Txns Hide Txns

27-Apr-22 6:47 PM View:	25-Apr-22 Grant 0	Kostas Odysseas D Director		Theravance Inc. - INVA	16% 79.56K to 92.21K	0	0	--	--	Show Txns Hide Txns

27-Apr-22 6:48 PM View:	25-Apr-22 Grant 0	Schlesinger Sarah J. Director		Theravance Inc. - INVA	17% 75.56K to 88.21K	0	0	--	--	Show Txns Hide Txns

27-Apr-22 6:51 PM View:	25-Apr-22 Grant 0	Haimovitz Jules Director		Theravance Inc. - INVA	14% 87.76K to 100.41K	0	0	--	--	Show Txns Hide Txns

27-Apr-22 6:49 PM View:	25-Apr-22 Grant 0	Dipaolo Mark Director		Theravance Inc. - INVA	17% 75.56K to 88.21K	0	0	--	--	Show Txns Hide Txns

22-Nov-22 4:30 PM View:	18-Nov-22 Payment of Exercise ($11.22K)	Zhen Marianne Chief Accounting Officer		Theravance Inc. - INVA	12% 34.46K to 38.65K	0	0	--	--	Show Txns Hide Txns

27-Apr-22 6:53 PM View:	25-Apr-22 Grant 0	Birx Deborah Director		Theravance Inc. - INVA	42% 29.84K to 42.49K	0	0	--	--	Show Txns Hide Txns